Foundry Partners, LLC Neogenomics Inc Transaction History

Foundry Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 23, 2021	SELL	$36.62 - $51.69 $1.57 Million - $2.22 Million	-42,861 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$41.56 - $59.88 $1.37 Million - $1.97 Million	-32,915 Reduced 43.44%	42,861 $2.07 Million
Q4 2020 Feb 04, 2021	SELL	$36.08 - $56.47 $13,566 - $21,232	-376 Reduced 0.49%	75,776 $4.08 Million
Q3 2020 Oct 23, 2020	SELL	$33.26 - $40.48 $28,237 - $34,367	-849 Reduced 1.1%	76,152 $2.81 Million
Q2 2020 Aug 03, 2020	BUY	$24.21 - $31.02 $195,592 - $250,610	8,079 Added 11.72%	77,001 $2.39 Million
Q1 2020 May 08, 2020	BUY	$20.5 - $34.53 $1.41 Million - $2.38 Million	68,922 New	68,922 $1.9 Million

293

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.8B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundry Partners, LLC with notifications on news.